Fractyl Health says Revita cuts weight regain vs sham one year after GLP-1 discontinuation in REMAIN-1 trial

Fractyl Health, Inc.

Fractyl Health, Inc.

GUTS

0.00
  • Fractyl Health reported positive one-year randomized REMAIN-1 Midpoint Cohort data for its Revita DMR procedure in post-GLP-1 weight maintenance.
  • Modified intention-to-treat results showed 7.8% weight regain with Revita versus 13.0% with sham, a roughly 40% reduction.
  • Complete duodenal ablation subgroup retained about 81% of GLP-1 weight loss versus 48% with sham; regain 4.8% versus 13.0%.
  • Optimized subgroup retained about 84% versus 46% with sham; regain 4.1% versus 13.5%.
  • Next milestones flagged were REMAIN-1 Pivotal Cohort topline six-month data in early Q4 2026, potential FDA De Novo submission in late Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fractyl Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150600PRIMZONEFULLFEED9762201) on July 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.